Top Markets
Coin of the day
Neoleukin Therapeutics, Inc. Neoleukin Therapeutics, Inc.

Neoleukin Therapeutics, Inc.

NLTX
Rank in Stocks #26682
Neoleukin Therapeutics, Inc. (NLTX) is a biopharmaceutical enterprise focused... Neoleukin Therapeutics, Inc. (NLTX) is a biopharmaceutical enterprise focused on developing immune-based treatments for conditions such as cancer, inflammatory responses, and autoimmune diseases, utilizing its proprietary protein design technology. The company's leading investigational therapy is NL-201, a novel protein meticulously crafted to emulate the therapeutic effects of the IL-2/IL-15 cytokines. This product candidate is intended for the management of various malignancies, including renal cell carcinoma and melanoma. The organization, founded in 2003, was previously known as Aquinox Pharmaceuticals, Inc. before officially changing its name to Neoleukin Therapeutics, Inc. in August 2019. Its operations are based out of Seattle, Washington.
Share Price
$3.49
Last synced: 2023-12-19
Market Cap
$38.68M
Change (1 day)
0.00%
Change (1 year)
0.00%
Country
US
Trade Neoleukin Therapeutics, Inc. (NLTX)

Category

Stock price history for Neoleukin Therapeutics, Inc. (NLTX)
Highest end of day price: $3.45 on 2023-12-01

Lowest end of day price: $64.26 on 2014-03-01
Stock price history of Neoleukin Therapeutics, Inc. from 2014 to 2026
Annual Stock Price Performance
Year Performance
2023 54.08%
2022 -91.29%
2021 -59.35%
2020 43.82%
2019 289.17%
2018 -79.56%
2017 -28.51%
2016 28.68%
2015 63.39%
2014 0.00%
Stock price for similar companies or competitors
Company Stock price Change 1y% Country
$171.67 -
DE
$163.33 25.54%
DE
$38.00 22.72%
JP
$220.12 32.96%
CH
$21.01 11.96%
IN